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The identities of ligands interacting with protein tyrosine phosphatase (PTP) receptors to regulate neurite outgrowth remain mainly
unknown. Analysis of cDNA and genomic clones encoding the rat leukocyte common antigen-related (LAR) PTP receptor predicted a
small, 11 kDa ectodomain isoform, designated LARFN5C, containing a novel N terminal followed by a C-terminal segment of the LAR
fifth fibronectin type III domain. RT-PCR and Northern blot analysis confirmed the presence of LARFN5C transcripts in brain. Trans-
fection of COS cells with LARFN5C-Fc cDNA resulted in expression of the predicted protein, and Western blot analysis verified expression
of 11 kDa LARFN5C protein in vivo and its developmental regulation. Beads coated with rLARFN5C demonstrated aggregation con-
sistent with homophilic binding, and pull-down and immunoprecipitation assays demonstrated that rLARFN5C associates with the LAR
receptor. rLARFN5C binding to COS cells was dependent on LAR expression, and rLARFN5C binding to LAR / hippocampal neurons
was fivefold greater than that found by using LAR-deficient (/) neurons. Substratum-bound rLARFN5C had potent neurite-
promoting effects on LAR / neurons, with a fivefold loss in potency with the use of LAR / neurons. rLARFN5C in solution at low
nanomolar concentrations inhibited neurite outgrowth induced by substratum-bound rLARFN5C, consistent with receptor-based func-
tion. These studies suggest that a small ectodomain isoform of a PTP receptor can function as a ligand for the same receptor to promote
neurite outgrowth.
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Introduction
Considerable evidence demonstrates that protein tyrosine phos-
phatase (PTP) receptors are important regulators of neurite out-
growth (Van Vactor, 1998; Chisholm and Tessier-Lavigne, 1999;
den Hertog, 1999; Bixby, 2000; Petrone and Sap, 2000; Stoker,
2001). Drosophila null mutant analyses suggest that the Drosoph-
ila leukocyte common antigen-related (Dlar) PTP receptor reg-
ulates neurite pathfinding during development (Krueger et al.,
1996; Desai et al., 1997). Null mutant crosses indicate that Dlar
modulates intracellular signaling mechanisms involving Robo
and DCC and that the opposing actions of Dlar and the Abelson
(Abl) tyrosine kinase control the phosphorylation state of the
Enabled (Ena) protein, a regulator of axonal actin assembly
(Wills et al., 1999; Bashaw et al., 2000; Lanier and Gertler, 2000).
Dlar functions in synaptic target recognition of Drosophila retinal
neurons (Clandinin et al., 2001; Maurel-Zaffran et al., 2001) and
interacts with liprin- to control synapse morphogenesis (Kauf-
mann et al., 2002). In leech neural development the inhibition of
HmLAR2 (an ortholog of Dlar) function leads to shortened and
aberrant neuronal projections, navigational crossover errors, and
growth cone collapse (Gershon et al., 1998; Baker and Macagno,
2000; Baker et al., 2000).
The mammalian leukocyte antigen-related (LAR) PTP recep-
tor also plays an important role in regulating neurite outgrowth.
LAR mRNA is expressed in neurons (Longo et al., 1993;
Schaapveld et al., 1998), LAR protein is present along neurites
and in growth cones (Zhang et al., 1998), and LAR alternative
splicing is coordinated in a spatiotemporal manner during devel-
opment (Zhang and Longo, 1995). Studies in LAR-deficient
transgenic mice have demonstrated decreased cholinergic fiber
innervation of the hippocampal dentate gyrus (Yeo et al., 1997;
Van Lieshout et al., 2000) and markedly impaired post-injury
sciatic nerve regeneration (Xie et al., 2001).
Key steps in elucidating PTP mechanisms modulating neurite
outgrowth will be the identification of ligands interacting with
PTP receptors and the identification of subdomains mediating
such interactions. In some cases neurite outgrowth might be reg-
ulated via PTP homophilic interactions. Recombinant proteins
corresponding to full-length ectodomains of PTP, PTP, and
PTP exhibit homophilic binding, and their addition to cultured
neurons promotes neurite outgrowth (Bixby, 2000). Whether
this neurite-promoting activity is mediated via homophilic inter-
actions or heterophilic interactions with heretofore-unidentified
receptors remains unknown. In addition, the specific PTP extra-
cellular subdomains regulating neurite outgrowth remain to be
identified.
We postulated that patterns of LAR ectodomain alternative
Received Sept. 11, 2002; revised Jan. 30, 2003; accepted Feb. 6, 2003.
This work was supported by National Institutes of Health Grant R01 AG09873. We thank Dr. Q. Yu for providing
full-length LAR cDNA and Dr. Marc Tessier-Lavigne at University of California, San Francisco for helpful discussions
regarding novel ligand–receptor mechanisms regulating neurite outgrowth. We also thank Weining Yin for out-
standing technical assistance.
Correspondence should be addressed to Dr. Frank M. Longo, University of North Carolina School of Medicine,
Department of Neurology CB7025, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599. E-mail:
longof@glial.med.unc.edu.
Copyright © 2003 Society for Neuroscience 0270-6474/03/233353-11$15.00/0
The Journal of Neuroscience, April 15, 2003 • 23(8):3353–3363 • 3353
splicing might provide useful clues for the identification of
ectodomain segments likely to be involved in ligand–receptor
interactions. A retained intron present between the fifth and sixth
fibronectin type III (FNIII) domains of LAR introduces an in-
frame stop codon predicting a truncated ectodomain isoform
(Zhang and Longo, 1995). We hypothesized that a truncated LAR
ectodomain isoform might exist that undergoes homophilic
binding and promotes neurite outgrowth. Support of this hy-
pothesis would indicate that LAR and perhaps other LAR-type
PTPs modulate neurite outgrowth via homophilic interactions.
Moreover, such studies would provide the first demonstration of
a PTP receptor subdomain capable of homophilic binding and
mediation of neurite outgrowth.
Materials and Methods
Isolation of genomic DNA and mRNA. Genomic DNA was isolated from
whole brain harvested from Sprague Dawley rats at the ages 2–3 months
via standard protocols. Rat brain poly(A) RNA was purchased from
Clontech (Palo Alto, CA). This poly(A) RNA was isolated by a modified
guanidinium thiocyanate method, followed by poly(A) RNA selection
that used at least three rounds of oligo-dT/cellulose purification. Poly(A)
RNA from mouse hippocampus was isolated with the Fast-Track kit
(Invitrogen, San Diego, CA).
Generation of clones containing the LASE-d Insert. Rapid amplification
of cDNA ends (RACE; Clontech) combined with nested PCR was used to
isolate cDNAs containing the LAR LASE-d insert. First-strand cDNA
product was derived by using 5 g of rat brain poly(A) RNA, and adapt-
ers were ligated to both ends. First-round PCR was conducted by using
the AP1 adaptor upstream primer and a downstream primer corre-
sponding to the 75 bp LASE-d insert (LASE-dA, 5-CCT GCT GCC CAC
CCA GCT TAG TCC CTG ACC CCT CAC TCA C-3). Second-round
PCR was conducted by using the nested AP2 upstream adapter primer
and a nested downstream primer corresponding to a further upstream
part of the LASE-d insert (LASE-dB, 5-CTG AAC AGC ACG CAC TGG
GCT CTG GTG CCG CCC TCC CTG C-3). PCR was performed with
annealing temperature at 72°C for 5 cycles each and at 68°C for 25 cycles.
PCR products were subcloned into the pCRII vector for DNA sequencing.
RT-PCR protocols were conducted as described previously (Zhang
and Longo, 1995). Transcripts containing the LASE-e and LASE-d re-
tained introns were detected by using an upstream primer corresponding
to a 5 site of the LASE-e intron (5-TGT CTC AGC TGA GAG CAG GAT
GGG TA-3) and a downstream primer corresponding to the LASE-d
retained intron (primer LASE-dA as listed above).
Northern blot analysis. Northern blot hybridization was performed
with the protocol described in the RNA detector Northern blotting kit
(KPL, Gaithersburg, MD). Poly(A) RNA (4 g) was electrophoresed
through a 1% agarose-formaldehyde gel and transferred to Hybond ny-
lon membranes (Amersham Biosciences, Arlington Heights, IL). Biotin-
labeled probes (with a specific activity of 50 ng/ml) were made with T7
RNA polymerase synthesized with the MAXIscript in vitro transcription
kit (Ambion, Austin, TX) by using PCR-derived, T7 promoter-
containing DNA templates corresponding to either the novel N terminal
or the LAR portion of LARFN5C.
Generation of LARFN5C antibody. LARFN5C rabbit antiserum was
produced by AnaSpec (San Jose, CA) with standard procedures. Rabbits
were injected with a purified synthetic peptide corresponding to residues
29 – 48 in the novel N terminal present in LARFN5C. Antibody (desig-
nated as LARFN5C 29 – 48 antibody) was purified by immunoaffinity
purification with the corresponding peptide.
Immunoprecipitation and Western blot analysis. Tissues were homoge-
nized in the following lysis buffer: 20 mM Tris, pH 8.0, 137 mM NaCl, 1%
NP-40, 10% glycerol, 1 mM PMSF, 10 g/ml aprotinin, and 1 g/ml
leupeptin. Lysates were centrifuged at 14,000  g for 10 min, supernatant
was collected, and protein concentrations were determined by the BCA
protein assay reagent (Pierce, Rockford, IL). Immunoprecipitations were
performed by adding LARFN5C 29 – 48 or LASE-c antibody (raised
against the nine amino acid LASE-c insert) (Zhang et al., 1998) and
incubating with 50 l of protein A/G agarose. Immunocomplexes were
centrifuged for 1 min at 14,000  g, washed three times in lysis buffer,
eluted with 50 l of 2 protein sample buffer, and boiled for 5 min; 25 l
was loaded per lane for electrophoresis. For immunoblots the samples
were electrophoresed through a NuPAGE 4 –12% Bis-Tris Gel with MES
(2-[N-morpholino]ethanesulfonic acid) SDS running buffer (Invitro-
gen) and transferred to polyvinylidene difluoride membranes. Western
blot signals were detected by the ECL chemiluminescence system (Am-
ersham Biosciences). To control for variations in protein loading, we
stripped and reprobed the blots with -actin monoclonal antibody (Sig-
ma, St. Louis, MO).
Pull-down assays. Pull-down assays were conducted as previously de-
scribed (Wills et al., 1999; Bashaw et al., 2000). Protein lysates of embry-
onic day 16 (E16) hippocampal tissues prepared as described above were
incubated for 1 hr with His-tagged fusion protein followed by pull down
with TALON resin pellets (Clontech). As a control for protein binding
specificity, lysates were incubated with resin pellets coated with Positope
control protein (Invitrogen) containing the following epitope tags:
Xpress, c-myc, V5, polyHis, HisG, thioredoxin, and green fluorescent
protein. Bound resin pellets were washed three times with lysis buffer.
Eluted proteins were assessed with the Western blot protocol described
above.
Production, purification, and characterization of recombinant LARFN5C.
The pLARFN5C cDNA clone was amplified by RT-PCR, using rat brain
mRNA, a sense primer corresponding to a region 9 bp upstream of the
putative ATG translation start codon, and an antisense primer corre-
sponding to a site within the LASE-d insert 37 bp downstream from the
LASE-d stop codon. The sense primer contained an added EcoRI site
(5-GG GAA TTC TGC TCA GTG ATG CAG GGA CTT G-3), and the
antisense primer contained an added HindIII site (5-CC CTC AAG CTT
GCT GCC CAC CCA GCT TAG TCC CTG ACC CCT CAC TCA C-3).
The amplified fragment was digested with EcoRI and HindIII and ligated
into the pBlueBacHis.2B vector (Invitrogen). The sequence of the resulting
expression construct was confirmed via automated DNA sequencing (Se-
qwright, Houston, TX). The pBlueBacHis.2B–LARFN5C expression con-
struct was used to transfect Sf9 insect cells via a standard recombinant pro-
tein expression protocol (Invitrogen). The His-tagged recombinant protein,
termed rLARFN5C, was purified with the TALON Superflow Metal Affinity
Resin Purification System (Clontech).
To synthesize a cDNA construct expressing a chimeric LARFN5C-Fc
protein, we amplified a PCR product corresponding to full-length
LARFN5C by using a 5 primer containing a BamHI restriction site and a
3 primer containing SpeI. The BamHI/SpeI-digested fragment of the
PCR product was ligated into the Fc-containing pGEM7 vector. A
BamHI/XhoI-digested 1.0 kb fragment (LARFN5C-Fc) was cloned into
the pcDNA3.1 expression vector (Invitrogen). Sequence and reading
frame were verified by automated DNA sequencing (Seqwright).
Microsphere aggregation assays. Fluorescently labeled microspheres
(1.75 m in diameter; Polysciences, Warrington, PA) were incubated
in 300 g/ml solutions of either rLARFN5C or bovine serum albumin
(BSA) in PBS overnight at room temperature. Microspheres were
blocked with 0.25 M ethanolamine for 30 min at room temperature and
then with 10 mg/ml BSA in PBS for an additional 30 min. After blocking,
the microspheres were washed three times with PBS, suspended in 50 l
of PBS, sonicated, and then incubated in 96-well plates at room temper-
ature for 1 hr on a rotary shaker. For antibody inhibition experiments the
antibody was added to the 50 l incubation solution to a final concen-
tration of 10 g/ml. Then 10 l aliquots were removed and examined on
microscope slides under a fluorescence microscope at a wavelength of
590 nm.
Experimental animals. LAR-deficient (LAR /) transgenic mice
have been described previously (Skarnes et al., 1995; Yeo et al., 1997; Xie
et al., 2001). A transgene located near the N-terminal encoding region of
the LAR gene and containing a splice acceptor linked with a cassette
encoding -geo creates a “gene trap” resulting in highly truncated LAR
transcripts encoding only a part of the N-terminal Ig region, followed by
the -geo protein. Thus in most transcripts almost the entire ectodo-
main, along with the entire catalytic endodomain, is absent. Long-range
splicing skipping the transgene insert results in trace expression of 8
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and 7 kb LAR transcripts. Expression of an 6 kb LAR transcript
(possibly regulated via a second, further downstream, promoter) occurs
at similar levels in LAR / and / mice. LAR / and LAR /
littermates were derived via heterozygous crosses.
Cell culture. COS-7 cells were maintained in DMEM containing 10%
fetal bovine serum (FBS) and incubated at 37°C with 5% CO2. Dissoci-
ated hippocampal neurons were obtained from E18 LAR/ and
LAR/ mice hippocampi via established protocols (Goslin et al., 1998)
and maintained in DMEM/F12 medium supplemented with 10% FBS.
Neurons from LAR/ and LAR/ mice were cultured in four-
chamber slides coated with 10 g/ml poly-L-lysine for 24 hr. For binding
experiments the COS cells or neurons were incubated with rLARFN5C at
the indicated concentrations for 3 hr at 37°C with 5% CO2. Cells were
rinsed twice with PBS, fixed with 4% paraformaldehyde (PFA) for 20
min, and then washed twice with PBS.
Transfection of COS-7 cells. COS-7 cells were plated at low (for immu-
nostaining) or high (for protein expression assays) density overnight.
Lipofectamine (60 l; Invitrogen) was preincubated with 3.0 g of cDNA
(for LAR) or 4.0 g of cDNA (for LARFN5C-Fc) in 1 ml of DMEM
transfection medium at room temperature for 15 min. cDNA consisted
of the pBabe vector or pcDNA3.1 vector without insert (null) or contain-
ing full-length LAR (Weng et al., 1998) or full-length LARFN5C-Fc. The
volume of the transfection solution was brought up to 6 ml and layered
over cells for 3 hr at 37°C. After transfection the LAR-expressing cells
prepared for immunostaining were incubated in DMEM containing 10%
FBS and then fixed at 24 hr. LARFN5C-Fc-expressing cells were incu-
bated in a T-75 flask in a volume of 12 ml virus production serum-free
medium (VP-SFM) with 10 ng/ml epidermal growth factor (EGF). At 48
hr the culture medium was collected without disruption of the attached
cell monolayer and then centrifuged to ensure the removal of any floating
cells. Culture medium (2 ml) was lyophilized and then resuspended in
170 l of protein lysis buffer. LARFN5C-Fc-transfected cells were har-
vested from the T-75 flask via the addition of lysis buffer and processed
for subsequent Western blot analysis. The chimeric LARFN5C-Fc pro-
tein was detected by using peroxidase-conjugated AffiniPure goat anti-
mouse IgG Fc fragment-specific antibody (Jackson ImmunoResearch,
West Grove, PA).
Immunofluorescent staining and quantification. Fixed COS cells or hip-
pocampal neurons were blocked in 3% normal serum and 1% BSA in
PBS for 2 hr. Then they were incubated for 36 hr at 4°C in a mixture
containing antibodies directed against the LAR N terminal (monoclonal
antibody, 1:800; BD Transduction Laboratories, Franklin Lakes, NJ) and
0.1 g/ml LARFN5C 29 – 48 rabbit polyclonal antibody. Secondary anti-
bodies consisting of Cy3 red-conjugated donkey anti-mouse (Jackson
ImmunoResearch) and Alexa 488 green-conjugated goat anti-rabbit IgG
(1:250; Molecular Probes, Eugene, OR) were applied for 2 hr at room
temperature in the dark. Fluorescent signal was detected with a confocal
microscope (Leica Laser Confocal TCS SP) through a 40 oil immersion
lens. For GAP-43 immunostaining the cells were treated after fixation
with 0.1% Triton X-100 for 10 min at room temperature and then incu-
bated with GAP-43 rabbit polyclonal antibody (1:400; Chemicon, Te-
mecula, CA). Secondary antibody consisted of Alexa 488 green-
conjugated goat anti-rabbit IgG (Molecular Probes).
Quantification of fluorescent staining was performed with the NIH
Image program. For COS cells the fluorescent density measurements
were made in five randomly selected 30  30 pixel fields per cell. Under
each condition 15 cells were selected randomly for assessment, generat-
ing a total of 75 measurements. For neurons the measurements were
made in three randomly selected 15  15 pixel fields per cell. Under each
condition 10 cells were selected randomly for assessment, generating a
total of 30 measurements.
Cell attachment and neurite outgrowth assays. Six-well plates were
coated with nitrocellulose (0.5 cm 2/ml) (Wang and Bixby, 1999). Test
proteins were prepared in PBS solutions and applied as 5 l droplets to a
designated midpoint in each well, followed by incubation for 1 hr at
37°C. Remaining substratum binding sites were blocked with 1% BSA in
PBS for 1 hr. As negative control, aliquots of rLARFN5C were subjected
to immunoprecipitation with His tag or LASE-c antibody. Dissociated
E18 hippocampal neurons were plated in culture media at a density of
1  10 5 to 1  10 6 cells per well. After 2 hr the wells were washed three
times with PBS and fixed with 2.5% glutaraldehyde. The number of
substrate-attached cells per field was counted in each of 10 –15 fields per
well. Fields were selected systematically by counting parallel rows of ad-
jacent fields. For neurite outgrowth assays E18 hippocampal neurons
were cultured for 24 hr. After fixation systematically selected adjacent
fields in parallel rows were photographed. In a blinded manner the neu-
rite length for each neurite longer than one cell body diameter was
measured.
Results
LAR alternative splicing predicts a novel LAR protein isoform
A rat cDNA clone (pLARFN5C) was obtained in which the 75 bp
LASE-d insert was followed upstream by the exon encoding the
C-terminal half of the LAR FNIII-5 domain and the exon encod-
ing the 27 bp LASE-c insert (Fig. 1A,D). Upstream from the
LASE-c exon was 350 bp of novel sequence likely representing a
retained intron. This retained intron was termed LASE-e (LAR
alternatively expressed element-e). The open reading frame
(ORF) created by the furthest downstream ATG potential start
codon present in the LASE-e insert extending to the furthest
upstream stop codon present in the LASE-d insert predicted an
11 kDa isoform termed LARFN5C. The LARFN5C sequence
predicted a protein with a novel N terminal containing 49 resi-
dues not present in constitutive LAR, followed by the nine resi-
due LASE-c insert, the 37 residue C terminus half of the FNIII-5
domain, and four residues present before the LASE-d in-frame
stop codon (Fig. 1B). Analysis of the predicted LARFN5C se-
quence for signal peptide motifs that used the combined neural
network approach described by Nielsen et al. (1997) demon-
strated potential cleavage sites at residues 14 (Y score  0.17) and
35 (Y score  0.27; the higher Y score indicates the most likely
cleavage site). The S score average over residues 1–14 was 0.56
(values 0.5 are consistent with a segment constituting a signal
peptide) and over residues 1–35 was 0.38. Thus sequence analysis
raised the possibility of a secretory signal at the LARFN5C N
terminal although the more typical pattern for known secreted
proteins of the S score averaging 0.5 over the most likely pre-
dicted cleaved fragment was not present.
To characterize the LASE-e retained intron on the genomic
level, we derived a rat genomic DNA clone by using a down-
stream primer corresponding to LASE-c and an upstream primer
corresponding to a site within the N-terminal portion of the
FNIII-5 domain. The resulting 2.7 kb PCR product was sub-
cloned into the pCRII vector and sequenced. Sequence analysis
demonstrated that the LASE-e intron was 2.7 kb in length and
directly linked the exons encoding the N-terminal half of the
FNIII-5 domain and the exon encoding LASE-c (Fig. 1C,D).
Downstream of the LASE-c exon an intron of 1.3 kb in length
was identified via PCR amplification of genomic DNA by using
an upstream primer corresponding to the LASE-c exon and a
downstream primer corresponding to the FNIII-5 C-terminal
exon (Fig. 1C,D).
LARFN5C isoform transcripts and protein are present in
vivo, and protein levels are regulated developmentally
The presence of mRNA encoding LARFN5C (transcripts con-
taining the LASE-e and LASE-d retained introns) was assessed in
poly(A) mRNA extracted from rat brain by RT-PCR. LARFN5C
transcripts were detected by using primers corresponding to sites
within LASE-e and LASE-d and generating an expected 534 bp
product. LARFN5C transcripts were present in adult brain and
embryonic hippocampus (Fig. 2A). Using a riboprobe corre-
sponding to the 150 nucleotides encoding the novel N terminal of
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LARFN5C, we identified an 1.6 kb tran-
script in hippocampal tissue (Fig. 2B). Us-
ing a riboprobe corresponding to the 147
nucleotides encoding the LASE-c and
FNIII-5 regions of LARFN5C, we detected
8 kb (the size expected for LAR) and
1.6 kb transcripts (Fig. 2B). Detection of
the 1.6 kb transcript by both the novel N
terminal and LAR probes was consistent
with the previous cDNA and RT-PCR re-
sults suggesting a novel alternatively
spliced LAR transcript containing the re-
gion encoding the novel N terminal. The
relative levels of LARFN5C and LAR tran-
scripts were similar, with a slightly in-
creased ratio of LARFN5C to LAR in post-
natal day 21 (P21) as compared with adult
hippocampus (Fig. 2C).
For protein expression studies mouse
tissues were used to take advantage of the
availability of LAR-deficient transgenic
mice as described below. Western blot
analysis of mouse E16 hippocampal tissue
extracts that used LARFN5C 29 – 48 anti-
body directed against residues present in
its N terminus and absent in LAR demon-
strated an 11 kDa signal consistent with
that predicted for LARFN5C (Fig. 2D). A
band between the 38 and 49 kDa markers
was detected also. As predicted by the pres-
ence of the LASE-c insert within
LARFN5C, analysis with LASE-c antibody
also detected an 11 kDa band. LASE-c
antibody also detected a band at 22 kDa
and two bands between the 38 and 49 kDa
markers. Incubation of blots in the ab-
sence of primary antibody, with preim-
mune serum, or with LARFN5C 29 – 48
antibody preincubated with LARFN5C
29 – 48 peptide resulted in loss of signal
(Fig. 2D). To confirm further the presence
of LARFN5C protein in tissue extract, we
performed a series of reciprocal immuno-
precipitations with LARFN5C 29 – 48 and
LASE-c antibodies. Western blot analysis
that used LARFN5C 29 – 48 antibody detected 11 and 44 kDa
species in immunoprecipitates formed with both LARFN5C and
LASE-c antibodies (Fig. 2E). In reciprocal studies Western blot
analysis that used LASE-c antibody detected 11 and 44 kDa
species in immunoprecipitates formed with LARFN5C 29 – 48
and LASE-c antibodies. No 11 and 44 kDa signals were de-
tected in immunoprecipitates formed with preimmune sera.
Together, Western blot analyses along with reciprocal immuno-
precipitations confirm the presence of LARFN5C protein in hip-
pocampal tissue extracts. The persistent detection of the 44 kDa
band in immunoprecipitates along with Western analyses raised
the possibility of the presence of LARFN5C in a tetrameric state
(assessed below).
Similar levels of LARFN5C protein were present in hippocam-
pal tissues and E18 cultured hippocampal cells obtained from
LAR / and / mice, consistent with previous studies (Yeo
et al., 1997) showing that expression of truncated LAR transcripts
is not reduced in LAR / mice (Fig. 2F). In LAR / mice the
LARFN5C levels were highest in E16 hippocampal tissue and
decreased during development. Interestingly, Western blot anal-
ysis of cell as well as tissue extracts demonstrated an 44 kDa
band along with the expected 11 kDa band. Quantitation of the
11 kDa signal showed a 17-fold reduction in LARFN5C levels
during development (Fig. 2G). Similar developmental regulation
of the 11 kDa LARFN5C protein also was demonstrated in
cortex and spinal cord tissue (data not shown).
Expression and purification of recombinant LARFN5C
An EcoRI–HindIII restriction enzyme fragment of the pLARFN5C
insert was cloned into the pBlueBacHis.2B vector for expression in
Sf9 cells. The expected product consisted of an 16 kDa protein
containing a His tag, followed by 45 vector-based residues con-
taining an enterokinase cleavage site and the 99 LARFN5C resi-
dues encoded by pLARFN5C. His tag-based purification from
Sf9 cell preparations yielded the expected 16 kDa protein as
detected by GelCode Blue staining of SDS-PAGE gels (Fig. 3A). A
Figure 1. Genomic organization and alternative splicing predicting the LARFN5C isoform. A, Full-length LAR contains three IgG
domains, eight FNIII domains, a transmembrane (TM) domain, and two PTP catalytic domains (D1, D2). LASE-c is a nine residue
insert introduced into the FNIII-5 domain by alternative splicing. B, C, Genomic and cDNA sequence analysis demonstrated the
LASE-e retained intron immediately upstream of the exon encoding LASE-c and the LASE-d retained intron immediately down-
stream of the exon encoding the C-terminal half of the FNIII-5 domain (FNIII-5C). The most downstream in-frame ATG start site in
LASE-e and the upstream most in-frame TGA stop site in LASE-d are shown and predict an 11 kDa isoform consisting of a 49
residue N terminal followed by the LASE-c and FNIII-5C domains. Constitutive LAR transcript splicing is indicated by the bottom
thicker splice indicator line, and alternative splicing is shown by the top thinner lines. D, Genomic sequence demonstrates the
splice donor (gt underlined) and splice acceptor (ag underlined) sites of the 2.7 kb LASE-e retained intron and the 1.3 kb
intron separating the LASE-c and FNIII-5C exons. Exonic sequence is shown in uppercase letters and intronic in lower case letters;
LARFN5C novel exonic sequence is shown in lower case letters with amino acid translation; stop codons are boxed. Antibody
LARFN5C 29 – 48 was raised against a synthetic peptide corresponding to N-terminal residues PGPLQAKPFTILSPFLSSRC.
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faint band at 64 kDa was also present. Higher-resolution West-
ern blots that used the LASE-c antibody revealed bands at 16,
32, and 64 kDa (Fig. 3A). The detection of the 32 and 64
kDa bands suggested the possibility of LARFN5C homophilic
binding resulting in the presence of rLARFN5C dimeric and tet-
rameric complexes. Enterokinase cleavage of rLARFN5C yielded
the expected 11 kDa protein species detected by GelCode Blue
Figure 2. RT-PCR, Northern blot, and Western blot analysis of LARFN5C expression. A, RT-
PCR analysis was performed by using an upstream primer corresponding to a site within LASE-e
and a downstream primer corresponding to a site within LASE-d generating a predicted product
of 534 bp. Poly(A) mRNA (0.05 g/reaction) from rat whole brain and rat E16 hippocampus was
assessed. H2O served as a negative control. B, Northern blot analysis of P21 hippocampal poly(A)
RNA was conducted by using a riboprobe corresponding to the 150 nucleotides encoding the
novel N terminal of LARFN5C (P1) or corresponding to the 147 nucleotides encoding the LASE-c
and FNIII-5 regions of LARFN5C (P2). P1 detected an 1.6 kb transcript, and P2 detected an
1.6 kb transcript of identical size as well as the expected LAR 8 kb transcript. C, Northern
blot autoradiograms derived by using the P2 probe and RNA isolated from P21 and adult (Ad)
hippocampus were assessed by scanning densitometry; the ratio of LARFN5C (1.6 kb) over
the LAR (8 kb) signal was calculated (mean  SE; n  6 blots). A small but significant
decrease in this ratio was detected in the adult when compared with the P21 samples ( p 	
0.05, Mann–Whitney). D, Protein extract (40 g) from E16 mouse hippocampal tissue was
applied to each lane. Blots were incubated with the indicated antibodies. Negative controls
included omission of primary antibody, use of preimmune antiserum, and preincubation of
primary antibody with LARFN5C 29 – 48 peptide. LARFN5C 29 – 48 and LASE-c antibodies de-
tected an 11 kDa protein (bottom arrow) consistent with the predicted size of LARFN5C. Both
antibodies also detected an 44 kDa signal (top arrow). E, E16 hippocampal tissue extracts
were immunoprecipitated (IP) with preimmune, anti-LARFN5C 29 – 48, or LASE-c antibodies.
Western blot analysis of IPs with anti-LARFN5C 29 – 48 or LASE-c antibodies detected 11 and
44 kDa proteins. F, Protein extract (40 g) was applied to each lane at the indicated devel-
opmental time points from E16 hippocampal tissue and E18 cultured hippocampal neurons
derived from LAR / and / mice and hippocampal tissues. Blots were incubated with
LARFN5C 29 – 48 antibody followed by reprobing with actin antibody (bottom panel). Similar
levels of LARFN5C were present in tissue and cells derived from LAR / and / mice. G,
Western blot autoradiograms derived by using LARFN5C 29 – 48 antibody were assessed by
scanning densitometry. The ratio of LARFN5C signal over the actin signal demonstrated that
LARFN5C protein levels in the hippocampus decreased significantly during development by
94% (mean ratios  SE; p 	 0.05; n  4; ANOVA).
Figure 3. Purification of rLARFN5C and homophilic binding of rLARFN5C. A, Left, His-tagged
recombinant LARFN5C (rLARFN5C) protein was eluted from metal affinity resin and applied to a
4 –12% gradient polyacrylamide gel system. Staining with GelCode Blue reagent detected an
16 kDa protein along with a faint signal at 64 kDa. A, Right, Analysis that used the more
sensitive LASE-c antibody Western blot detected signal at 16, 32, and 64 kDa. B, Left,
Incubation of His-tagged rLARFN5C with enterokinase generated the predicted 11 kDa prod-
uct as detected by GelCode Blue staining. B, Right, Analysis that used the more sensitive
LARFN5C 29 – 48 antibody Western blots detected signal at 11, 22, and 44 kDa. C,
Fluorescent microspheres were coated with either BSA (top two panels) or rLARFN5C (remain-
der of panels), sonicated for 30 sec, incubated for 1 hr without or with the indicated antibodies,
and then examined under fluorescent microscopy. BSA-coated microspheres remained dissoci-
ated, whereas rLARFN5C-coated microspheres in the absence of antibody or in the presence of
preimmune antibodies underwent aggregation. LARFN5C 29 – 48 or LASE-c antibodies blocked
aggregation.
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staining (Fig. 3B) and was used in subsequent studies to compare
bioactivity of the 16 and 11 kDa species. Western blot analy-
sis of cleaved rLARFN5C that used the LARFN5C 29 – 48 anti-
body revealed bands at 11, 22, and 44 kDa (Fig. 3B), again
pointing to the possibility of the presence of LARFN5C in dimeric
and tetrameric complexes. Interestingly, the 11, 22, and 44
kDa banding pattern revealed by Western blot analysis of purified
rLARFN5C was similar to the pattern revealed with analysis of
tissue extracts.
rLARFN5C induces aggregation of microspheres
The possibility that rLARFN5C undergoes homophilic binding
was tested directly with microsphere aggregation assays. Micro-
spheres coupled with rLARFN5C demonstrated marked aggrega-
tion within 1 hr of incubation (Fig. 3C). In contrast, BSA-coupled
microspheres demonstrated no clear aggregation under the
same conditions. To confirm that aggregation was specific to
rLARFN5C rather than a contaminant, we added LARFN5C 29 –
48, LASE-c antibodies, or preimmune serum to the aggregation
solution. Supporting a role for rLARFN5C itself mediating aggre-
gation, each of these antibodies, but not preimmune serum,
blocked aggregation (Fig. 3C).
Homophilic binding by rLARFN5C predicted that
rLARFN5C also might bind to LAR. Protein pull-down assays
with His-tagged rLARFN5C were used to determine whether
rLARFN5C captures the 150 and 110 kDa LAR ectodomain
isoforms present in neural tissues. Western blot analysis of
LAR / E18 hippocampal extracts that used the LAR N-terminal
antibody (Zhang et al., 1998) demonstrated only trace expression of
the LAR 150 and 110 kDa isoforms (Fig. 4A). Consistent with
the persistent expression of LAR6 kb transcripts in LAR/mice
(Yeo et al., 1997), expression of an 80 kDa isoform was relatively
unchanged. Incubation of rLARFN5C-coated metal affinity resin
with LAR / extracts demonstrated the capture of 150, 110,
and 80 kDa LAR isoforms (Fig. 4B). Parallel incubations per-
formed with LAR / extracts failed to detect capture of the 150
and 110 kDa proteins. The sizes of these proteins, their detection
by the LAR N-terminal antibody, and their absence in LAR-deficient
cells indicated that rLARFN5C bound to the LAR ectodomain. The
80 kDa protein captured by rLARFN5C likely represents an LAR
isoform with persistent expression in LAR / neurons. Applica-
tion of beads coated with the His-tagged Positope control protein
resulted in the absence of pulled down proteins and confirmed that
binding of the 150, 110, and 80 kDa species was dependent on
the presence of rLARFN5C.
To assess further the interaction between LARFN5C and LAR,
we immunoprecipitated E16 hippocampal tissue extracts with
LARFN5C N-terminal 29 – 48 antibody or preimmune serum,
and we analyzed immune complexes by SDS-PAGE, followed by
Western blotting with LAR N-terminal antibody. As shown in
Figure 4C, 150 and 110 kDa LAR isoforms were found to coim-
munoprecipitate with LARFN5C, thereby offering a second line of
evidence that LARFN5C interacts with the LAR ectodomain.
Expression of rLARFN5C protein by COS cells
To verify further that the sequence encoding the novel N terminal
of LARFN5C is translated and to determine whether LARFN5C
protein could be detected in culture medium, we transfected COS
cells with cDNA encoding a LARFN5C-Fc chimera with the Fc
portion located at the C terminal. Western blot analysis that used
Fc antibody detected the expected 42 kDa LARFN5C-Fc fusion
protein in both the cell pellet and culture media of LARFN5C-Fc
cDNA-transfected cells, but not in fractions of cells that were
transfected with the null vector (Fig. 4D).
rLARFN5C binding to COS cells is dependent on
LAR expression
To determine whether LARFN5C binds to LAR in the physiolog-
ical context of cell surface binding, we compared LARFN5C
binding to COS cells by using LAR- and null-transfected COS
Figure 4. LAR Western blot, rLARFN5C pull-down, LARFN5C immunoprecipitation, and
rLARFN5C-Fc expression assays. A, Western blot analysis that used the LAR N-terminal antibody
assessed LAR protein expression in extracts prepared from E18 hippocampal cultures derived
from LAR / and / mice. Blots were reprobed with -actin antibody to control for
differences in loading (bottom panel). In LAR / extracts only trace levels of the LAR 150
kDa (top arrow) and 110 kDa (middle arrow) isoforms were present, whereas similar levels of
the 80 kDa (bottom arrow) isoform were present in LAR / and / samples. B, For
pull-down assays E18 hippocampal extracts were incubated with metal affinity resin coated
with His-tagged rLARFN5C or His-tagged Positope control protein. After incubation the resin
was washed, and bound proteins were eluted and assessed via Western blots with LAR
N-terminal antibody. Incubation of extracts with His-tagged Positope failed to pull down pro-
tein detected by the LAR antibody (lanes 1, 2). Incubation of LAR / extracts with His-
tagged rLARFN5C resulted in the capture of 150 kDa (top arrow), 110 kDa (middle arrow),
and 80 kDa (bottom arrow) proteins detected by LAR antibody (lane 3). Incubation with LAR
/ extract failed to detect the 150 and 110 kDa isoforms (lane 4), consistent with their
relative absence in LAR / tissue. C, E16 hippocampus lysates were immunoprecipitated
with preimmune or LARFN5C 29 – 48 antibody, and immune complexes were analyzed by
Western blotting with the use of LAR N terminus monoclonal antibody. LAR 150 kDa (top
arrow) and 110 kDa (bottom arrow) isoforms were found to coimmunoprecipitate with
LARFN5C, but not with preimmune antibody. The bottom band at 55 kDa is consistent with
nonspecific IgG binding. D, COS cells were transfected with pcDNA3.1 vector in the null form or
containing the LARFN5C-Fc insert. Western blot analysis of cell pellet extract and culture me-
dium collected at 48 hr, which used Fc fragment-specific antibody, detected the expected 42
kDa LARFN5C-Fc fusion protein.
3358 • J. Neurosci., April 15, 2003 • 23(8):3353–3363 Yang et al. • A LAR Ectodomain Promotes Neurite Outgrowth
cells. Previous studies demonstrated that LAR expression is ab-
sent or undetectable in COS cells (Weng et al., 1998). Immuno-
staining with the LAR N-terminal antibody verified that LAR was
expressed by LAR-transfected COS cells and that null-transfected
cells demonstrated no LAR expression (Fig. 5A). After the addi-
tion of rLARFN5C to cultures, LARFN5C 29 – 48 antibody dem-
onstrated the binding of rLARFN5C to LAR-expressing cells, but
no binding to null cells. Overlay of LAR and LARFN5C signal
revealed that most of the rLARFN5C signal was associated with
LAR signal. The relative levels of rLARFN5C binding to LAR-
expressing cells exhibited saturable kinetics over a low-to-mid
nanomolar range with an EC50 of 100 –200 nM (Fig. 5B). These
findings offered a third line of evidence that LARFN5C binds to
LAR. In addition, these studies demonstrated that LARFN5C
binding is not a result of nonspecific protein adhesiveness but
that LARFN5C binds to LAR in a manner consistent with ligand–
receptor interaction.
rLARFN5C binding to E18 hippocampal neurons is correlated
with LAR expression
The E18 hippocampal culture model, consisting primarily of py-
ramidal neurons, is a well established system for studies of neurite
outgrowth (Goslin et al., 1998; Esch et al., 1999), and LAR has
been shown to be expressed by pyramidal neurons in vivo (Longo
et al., 1993; Zhang et al., 1998). Immunostaining with the LAR
N-terminal antibody detected abundant signal associated with
LAR / neurons (Fig. 6A). To compare
binding of exogenously added rLARFN5C
with neurons with high versus low levels of
LAR expression under identical condi-
tions, we prepared mixed E18 cultures de-
rived from LAR/ (high LAR-expressing)
and / (low LAR-expressing) mice. LAR
immunostaining readily detected entirely
distinct populations of high LAR-expressing
and low LAR-expressing neurons, with an
average approximately fivefold greater LAR
signal in high-expressing neurons (Fig.
6A,B,D). Consistent with Western blot anal-
yses of LAR / and / hippocampal tis-
sue, staining with LARFN5C 29–48 anti-
body demonstrated similar levels of
endogenous LARFN5C signal associated
with high LAR-expressing and low LAR-
expressing neurons (Fig. 6A,D). Overlay of
LAR and LARFN5C signal indicated that
LARFN5C was associated primarily with
LAR signal in somal, neurite, and growth
cone regions. Omission of primary and
secondary antibodies resulted in an ab-
sence of signal (data not shown). The ad-
dition of rLARFN5C to culture medium
followed by cell washes resulted in an ap-
proximately fivefold higher LARFN5C sig-
nal associated with LAR high-expressing
neurons as compared with that found with
LAR low-expressing neurons (Fig. 6C,E).
These findings paralleled those derived
from COS cell studies and were consistent
with a model in which LARFN5C binds to
E18 hippocampal neurons, in part or pos-
sibly entirely, via a LAR-dependent
mechanism.
rLARFN5C promotes substratum attachment and neurite
outgrowth of E18 hippocampal neurons
The finding that rLARFN5C binds to LAR raised the possibility
that substratum-bound rLARFN5C might mediate E18 cell ad-
hesion and neurite outgrowth. Cell adhesion and neurite out-
growth assays were conducted by applying E18 hippocampal
neurons to nitrocellulose surfaces coated with BSA, laminin, fi-
bronectin, or rLARFN5C (Fig. 7A–E). After 2 hr the number of
neurons attached in rLARFN5C-coated wells was 10-fold higher
than that promoted by BSA and at an intermediate level between
that promoted by laminin and fibronectin. Immunoprecipitation
of rLARFN5C solutions with either His tag or LASE-c antibodies
eliminated cell adhesion activity (Fig. 7A), indicating that the
rLARFN5C protein, rather than a contaminant, contained this
activity.
Using the same nitrocellulose-based assays, we assessed the
effect of rLARFN5C on E18 hippocampal neuron neurite out-
growth. Morphological analysis demonstrated that the majority
of neurons cultured on rLARFN5C-coated nitrocellulose bore
one long primary process and one or more much shorter pro-
cesses (Fig. 7A–D). This pattern was consistent with previous
analyses of cultured pyramidal neurons in which one long pro-
cess characteristic of an axon is formed along with shorter pro-
cesses characteristic of dendrites (Goslin et al., 1998). In contrast,
neurons cultured on laminin generally were associated with one
Figure 5. LAR is required for rLARFN5C binding to COS cells. A, COS 7 cells were transfected with LAR (top row) or with null
vector (bottom row). After transfection the cells were incubated with rLARFN5C recombinant protein (625 nM) followed by
washes, immunostaining for LAR and LARFN5C, and confocal imaging. Column one shows COS cell morphology under differential
interference contrast (DIC), columns two and three demonstrate imaging for LAR by using Cy3 (red) and for LARFN5C by using
Alexa 488 (green), and column four shows image overlay. LARFN5C binding is entirely dependent on LAR expression; LARFN5C
signal is colocalized mainly with LAR (yellow), whereas a portion of LAR signal (red) remains independent of LARFN5C. Scale bar,
10 m. B, LARFN5C and LAR signal were measured for individual cells, and ratios were calculated over the indicated concentra-
tions of rLARFN5C (mean  SE; n  75).
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long process, consistent with previous ob-
servations showing that laminin preferen-
tially promotes axonal growth (Esch et al.,
1999). rLARFN5C-promoted processes
exhibited multiple deflections characteris-
tic of pyramidal cultures (Goslin et al.,
1998), whereas laminin-promoted pro-
cesses appeared longer and straighter.
Neurite outgrowth patterns observed by
using fluorescent GAP-43 antibody imag-
ing were similar to those seen by using
light microscopy (data not shown).
Quantitative analysis of the lengths of
the longest process of each neuron revealed
that the mean process length promoted by
rLARFN5C was intermediate between those
of laminin and fibronectin (Fig. 7F,G). Pre-
treatment of rLARFN5C by LASE-c and His
tag antibody immunoprecipitation substan-
tially reduced neurite-promoting activity,
confirming that the rLARFN5C protein,
rather than a contaminant, contained the
neurite-promoting activity.
To characterize further the neurite-
promoting function of rLARFN5C, we per-
formed dose–response studies. rLARFN5C
and its 11 kDa enterokinase cleavage
product promoted neurite outgrowth over
a similar low picomolar dose range (Fig.
7H). This finding indicated that the vector-
based His tag and leader sequence did not
augment or diminish neurite-promoting
activity. Administration of rLARFN5C in
solution resulted in no neurite-promoting
effect (data not shown). The possibility
that substratum-bound rLARFN5C pro-
motes neurite outgrowth via specific in-
teraction with LAR and possibly other re-
ceptors predicted that the addition of
rLARFN5C in solution would compete with
substratum-bound LARFN5C receptor
binding and thereby inhibit its neurite-
promoting activity. Over a concentration
range of 10–100 nM, rLARFN5C inhibited
the neurite-promoting effect of substratum-
bound rLARFN5C by 30% (Fig. 7I). It was of particular interest to
note that this inhibitory effect occurred at similar concentrations in
which rLARFN5C demonstrated dose-dependent binding to LAR
expressed by COS cells. This competitive inhibitory effect provided
further evidence that rLARFN5C functions via receptor-type inter-
actions rather than via nonspecific adhesive mechanisms. The ab-
sence of further inhibition at higher concentrations suggested that
rLARFN5C in solution did not function as a simple antagonist.
Other possibilities included functioning as a partial antagonist or
promoting neurite outgrowth via non-LAR receptors in the higher
concentration range.
Dependence of rLARFN5C promotion of neurite outgrowth
on the presence of neuronal LAR
The findings that rLARFN5C undergoes homophilic binding,
binds to the ectodomain of LAR, promotes neurite outgrowth of
LAR-expressing E18 neurons, and demonstrates competitive
properties are consistent with a model in which its neurite-
promoting activity is mediated, in part, via interaction with neu-
ronal LAR. The role for LAR in mediating rLARFN5C activity was
tested directly by conducting dose–response studies with E18
hippocampal neurons derived from LAR / and / mice.
The potency of laminin in promoting neurite outgrowth of LAR
/ and / neurons was equivalent, indicating the absence of
a nonspecific impairment of neurite outgrowth in LAR / neu-
rons (Fig. 8A). In contrast to laminin, rLARFN5C demonstrated
an approximately fivefold loss in potency when applied to LAR
/ neurons (Fig. 8B). It was of particular interest to note that
this degree of loss in potency was similar to the fivefold loss in
binding of rLARFN5C to LAR / neurons (Fig. 6E). These
findings further supported the hypothesis that rLARFN5C pro-
motes neurite outgrowth in part (or possibly entirely) via ho-
mophilic interaction with neuronal LAR. The persistence of
rLARFN5C-induced neurite outgrowth in LAR / neurons
was likely to have resulted either from persisting LAR expression
or, alternatively, via heterophilic mechanisms.
Figure 6. Exogenous rLARFN5C binding to high and low LAR-expressing neurons. A, E18 mouse hippocampal neurons derived
from LAR / and / embryos were combined and cocultured for 24 hr and coimmunostained with monoclonal LAR
N-terminal antibody and LARFN5C 29 – 48 antibody. As expected in cocultures of LAR / and / cells, populations of high
LAR-expressing and low LAR-expressing cells were evident (top vs bottom panel). LAR and endogenous LARFN5C signal is present
in cell bodies, along neurites, and in growth cones (arrowheads). Similar to COS cells, LARFN5C signal is colocalized mainly with
LAR (yellow), whereas a portion of LAR signal (red) remains independent of LARFN5C. Similar levels of endogenous LARFN5C
staining were observed in both high and low LAR-expressing cells. Signal overlay demonstrated minimal LAR–LARFN5C signal
(yellow) in low LAR-expressing cells. Scale bar, 10 m. B, Quantitation of LAR signal demonstrated distinct populations of cells:
high LAR-expressing and low LAR-expressing. C, The addition of exogenous rLARFN5C to culture media resulted in increased
LARFN5C signal associated with high LAR-expressing neurons as compared with low LAR-expressing neurons. Scale bar, 5 m. D,
Quantification of LAR and LARFN5C signal demonstrated a fivefold decrease in LAR signal in low LAR-expressing neurons and
similar levels of endogenous LARFN5C signal in high and low LAR-expressing neurons (mean  SE; n  30; ***p 	 0.001,
Mann–Whitney test). E, In cultures containing added rLARFN5C at 625 nM, the quantification of LAR and LARFN5C signal demon-
strated fivefold less LARFN5C signal associated with low LAR-expressing neurons as compared with that associated with high
LAR-expressing neurons (mean  SE; n  30; ***p 	 0.001, Mann–Whitney test).
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Discussion
Previously characterized LAR extracellular domain protein iso-
forms include the 150 kDa isoform corresponding to the full-
length 8 kb LAR transcript and the 110 kDa isoform corre-
sponding the 7 kb LAR transcript, omitting FNIII domains 4, 6,
and 7 (Zhang and Longo, 1995; Zhang et al., 1998). The present
study identifies a novel 1.6 kb LAR transcript encoding an 11
kDa isoform termed LARFN5C. LARFN5C contains a novel 49
residue N terminal followed by the nine residue LASE-c insert
and the C-terminal half of the LAR FNIII-5 domain. Multiple
lines of evidence indicate that LARFN5C binds via homophilic
interaction to itself and to the LAR ectodomain. LARFN5C forms
homodimer and homotetramer complexes, and rLARFN5C-coated
microspheres demonstrate aggregation blocked by rLARFN5C
antibodies. rLARFN5C pull-down assays capture LAR ectodo-
main isoforms, immunoprecipitation with rLARFN5C antibod-
ies results in capture of LAR ectodomain isoforms, and
rLARFN5C binding to COS cells is entirely dependent on LAR
Figure 7. Characterization of rLARFN5C neurite-promoting activity. E18 hippocampal neu-
rons were cultured for 24 hr on nitrocellulose coated with BSA ( A), laminin ( B), rLARFN5C ( C ),
or rLARFN5C ( D) subjected to His tag immunoprecipitation. After fixation the neurons were
immunostained with GAP-43 antibody, followed by Alexa 488 green-conjugated goat anti-
rabbit IgG. E, E18 hippocampal neurons were plated on nitrocellulose coated with the indicated
proteins (LN, laminin; FN, fibronectin). rLARFN5C was added to substrate either directly
(rLARFN5C) or after pretreatment via immunoprecipitation (IP) with His tag or LASE-c antibody.
BSA was included as an additional negative control. After 2 hr of incubation the cells were
washed and fixed. The mean number of cells (SE) present per field is shown. For laminin,
fibronectin, and rLARFN5C 200 –300 fields over a series of six separate studies were assessed.
For each of the three negative control conditions 50 fields were assessed in total. F, E18
hippocampal neurons were plated on nitrocellulose coated with the indicated proteins.
rLARFN5C was added to substrate either directly (rLARFN5C) or after pretreatment via IP with
His tag or LASE-c antibody. After 24 hr the neurite lengths were measured (mean  SE). For
laminin, fibronectin, and rLARFN5C 400 –900 neurites over a series of eight studies were
measured. For each of the three negative control conditions 10 – 60 neurites were measured. G,
Cumulative distribution of neurite length measurements (BSA, open circles; His tag IP, open
boxes; LASE-c IP, open triangles; FN, filled triangles; rLARFN5C, filled circles; LN, filled boxes). H,
E18 hippocampal neurons were plated on nitrocellulose substrate coated with the indicated
concentrations of rLARFN5C. For each dose that was tested 80 –250 neurites were measured.
4
Mean neurite length  SE is shown. Filled circles indicate results with 16 kDa uncleaved
rLARFN5C, and open circles indicate results with enterokinase-cleaved 11 kDa rLARFN5C. I,
E18 hippocampal neurons were plated on nitrocellulose substrate coated with 3.125 pmol of
rLARFN5C, and soluble rLARFN5C was added to culture medium at the indicated concentrations.
For each dose that was tested 70 –200 neurites were measured. Mean neurite length  SE is
shown.
Figure 8. rLARFN5C-induced neurite outgrowth is partially dependent on the presence of
neuronal LAR. A, E18 hippocampal neurons derived from LAR / (filled triangles) and LAR
/ (open triangles) mice were cultured in wells coated with laminin applied at the indicated
doses. After 24 hr the neurite lengths were determined (mean  SE; 80 –230 neurites were
measured for each genotype and each concentration). The potency of laminin in inducing neu-
rite outgrowth from LAR / neurons was unchanged. B, E18 hippocampal neurons derived
from LAR / and LAR / mice were cultured in wells coated with the rLARFN5C protein
applied at the indicated doses. After 24 hr the neurite lengths were determined (mean  SE;
70 –220 neurites were measured for each genotype and each concentration). rLARFN5C had a
fivefold loss of potency in LAR / cultures.
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expression. Three lines of evidence support a model in which
LARFN5C binds to E18 neurons and promotes neurite out-
growth, in part, via homophilic interaction with LAR. First,
rLARFN5C binding to E18 neurons is decreased in LAR-deficient
neurons. Second, soluble rLARFN5C inhibits the neurite-
promoting effects of substrate-bound rLARFN5C at concentra-
tions similar to those at which it binds to LAR. Third, the potency
of rLARFN5C in promoting neurite outgrowth decreases by five-
fold when applied to LAR / neurons. These studies are the
first to report a LAR isoform that demonstrates homophilic in-
teraction and that promotes neurite outgrowth.
The present findings point to the C-terminal half of the LAR
FNIII-5 domain as a candidate region important for binding by
LARFN5C and perhaps other LAR ligands. LARFN5C-to-
LARFN5C homophilic binding is likely to result from one of the
following three potential binding interactions: N-terminal to
N-terminal isologous homophilic binding, C-terminal FNIII-5
to C-terminal FNIII-5 isologous homophilic binding, or
C-terminal FNIII-5 to N-terminal heterologous homophilic
binding. The finding that LARFN5C binds to LAR and the ab-
sence of the LARFN5C N-terminal sequence in LAR make the
possibility of N-terminal to N-terminal isologous homophilic
binding unlikely. For either of the other binding scenarios, the C
terminal of the LAR FNIII-5 domain within full-length LAR is
likely to serve as the binding target. In the overall context of 150
kDa LAR-type PTP ectodomains, identification of this 6 kDa
segment as one candidate region modulating LAR-mediated neu-
rite outgrowth represents an almost 25-fold narrowing in size of
a core LAR-type segment mediating neurite outgrowth. Clearly,
these findings do not rule out the presence of other LAR subdo-
mains modulating neurite outgrowth. In current studies in our
laboratory, synthetic peptides corresponding to the C-terminal
FNIII region of LARFN5C, but not those corresponding to the
novel N terminal, demonstrate homophilic binding. These find-
ings point further to this domain as a key mediator of homophilic
binding and raise the possibility that LAR isoforms lacking the
LASE-e encoded N-terminal sequence also might demonstrate
homophilic binding.
A key mechanistic issue in PTP receptor function is whether
homophilic binding plays a role in PTP receptor regulation of
neurite outgrowth. The full-length ectodomain of the 140 kDa
PTP receptor promotes neurite outgrowth and binds to a 140
kDa neural protein, raising the strong possibility of homophilic
binding. Alternatively, heterophilic interaction via similarly sized
receptors remains possible (Wang and Bixby, 1999). PTP and
PTP full-length ectodomains undergo homophilic binding and
stimulate neurite outgrowth (Brady-Kalnay and Tonks, 1994;
Sap et al., 1994; Zondag et al., 1995; Burden-Gulley and Brady-
Kalnay, 1999; Drosopoulos et al., 1999). The determination of
whether these ectodomain neurite-promoting effects are medi-
ated via homophilic or heterophilic binding will benefit from the
application of PTP-, PTP-, and PTP-deficient neurons. In
the case of LAR and LARFN5C the availability of LAR-deficient
neurons, along with the findings in the present study, supports a
model in which promotion of neurite outgrowth by LAR and
possibly other LAR-type PTPs is mediated, at least in part, via
homophilic interaction.
Elucidation of functional roles of PTP ectodomains raises the
question of how the potency of rLARFN5C neurite-promoting
compares with that of other recombinant PTP ectodomains.
Given that the available data are limited to in vitro studies, differ-
ences in modes of protein application, the use of artificial sub-
strates, differences in orientation of bound proteins, and differ-
ences in the types of neurons tested clearly limit comparisons of
“potencies.” For PTP studies, recombinant protein was present
in solution at 10 g/ml (70 nM) in cultures of cerebellar granule
neurons (Drosopoulos et al., 1999). In PTP neurite-promoting
assays aliquots of 2– 4 g (10,000 –20,000 pmol; assayed with
retinal neurons) (Burden-Gulley and Brady-Kalnay, 1999) and in
PTP studies aliquots of 0.012– 0.100 g (80 –700 pmol; as-
sayed with forebrain neurons) (Wang and Bixby, 1999) were ap-
plied to similar areas of nitrocellulose substrates. In the present
studies rLARFN5C aliquots of 0.4 –7.0 pmol, a quantity 100- to
1000-fold less than the applications of PTP and PTP, were
sufficient for eliciting neurite outgrowth. Clearly, the actual rel-
ative potencies of LAR-type PTP ectodomains will be assessed
more accurately in physiological contexts. Although formal
receptor-binding studies are beyond the scope of the present
work, the ability of soluble rLARFN5C to bind to COS cell LAR
over a two-log dose range of 6 – 600 nM and to inhibit
substratum-bound rLARFN5C at similarly low nanomolar con-
centrations places LARFN5C at the lower end of concentration
ranges typical of FNIII or Ig cell domains promoting cell adhe-
sion or neurite outgrowth.
The unusual finding that a retained intron within a receptor
leads to the production of a small ectodomain protein isoform
that can function as a ligand for the same receptor to promote
neurite outgrowth is of particular interest and raises the possibil-
ity of potential endogenous functional roles of LARFN5C. For-
mal secretion studies will be required to determine whether the
LARFN5C N-terminal sequence is capable of mediating secretion
via conventional mechanisms, or, if not, whether LARFN5C se-
cretion occurs via a nonclassical pathway. Selective elimination of
the LARFN5C isoform or its function in vivo will be required to
determine whether LARFN5C has a physiological role. Regard-
less of the presence or absence of an endogenous physiological
function, identification of LARFN5C and its ability to bind LAR
and promote neurite outgrowth constitutes the first demonstra-
tion of a functional subdomain within a PTP receptor ectodo-
main and provides a novel basis for creating small molecule LAR-
based ligands for the purpose of positively or negatively
modulating neurite outgrowth. The identification of LARFN5C
also might provide a useful tool for identifying endogenous LAR
ligands, for elucidating LAR domains involved in their binding,
and for potentially modulating effects of endogenous ligands.
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